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  DKB is an antibiotic of aminoglucoside group and a kanamycin derivative having chemical
structure of 3’， 4’一dideoxy－kanamycin B． DKB was administered to the patients with ihtractable
urinary tract infection due to postoperatlve inlying catheters．
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  2） The highest blood level after intramuscular administration of 50 mg DKB was observed
at 30 minutes in two subjects with normal renai function． The blood level decreased to 1．33 mcg
／ml and 2，25 mcg／ml at ．six hours respectively， The highest urinary level was observed one to
two hours after injection． Six hours urinary recovery of the antibiotic was 60．3％ and 80．0％，
  3） Clinical evaluation was made on 16 patients．． Effectiveness rate was 68．7％， and if
limited with post－prostatectomy cases it was 66．6％，
  4） No side reaction was observed regarding hematological， renal function， liver function
examinations as far as five days adTninistration of leO mg per’day． Tinnitus and skin rash
was experienced in a case respectively．
























































 分離菌のMICはPs． aeruginosa 6株で1・56
mcg／mlから100 mcg／m1， E． coli 4株で1・56 mcg
／rnlから12．5mcg／ml， Prot． vulgaris 1株で3．13
mcg／ml， Prot， mirabilis 3株で0．78 mcg／m1から
50 mcg／m1， Klebsie〃a 1株で3．13 mcg／ml， Citro－





査室の保存血でばPs・aerecginosa 3・13 mc9／m1， E・






 早朝空腹時にDKB 50 mgを筋注し，30分，1時
間，2時間，4時間，6時間に採血および採尿した。
Susceptibility of bacteria isolated from ascending urinary tract infection to DKB
           （plate dilution method）
No． of MIC（mcg／m1）Organism strains
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Urine concentration and accumulative rate of urinary recovery of
DKB in rnale adults （50 mg， i． m．）．
628 福重。ほか：尿路逆行性感染・DKB











Before medication After medication
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．した． これによる．とPs． aeruginosa 8株中3株が
消失し，E． coli 4株は全株が消失した． Prot． vul一
福重・ほか：尿路逆行性感染．・DKB 629
（100mg／day， 5 days， i．m．）．
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garis 2話中1株， Prot． mirabilis 4株中2株，



















Table 3． Clinical effectiveness．




Renal and ureteral carcinoma




































































































aerecginosa 1．56 mcg／ml．vlOO mcg／ml， E． coli 1．
56mcg／mlN12．5mcg／ml， Prot． vulgaris 3．13 mcg
／ml， Prot． mirabilis O．78 mcg／m！N50 mcg／ml，
Klebsiella 3．13 rncg／ml， Citrobacter 6．25 rncg／rn1，
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